CropEditas™ is MaxEditas’ proprietary, fully customized CRISPR platform. Developed in-house to integrate in silico design, lab transformation, and rapid regeneration protocols for scalable, high-impact plant editing—from lab to field.
Targeting the world's toughest crops
Niche Specialization
We specialize in high-value specialty crops, such as peanut and citrus (including lime), where genetic manipulation is traditionally difficult. This focus allows us to overcome limitations in dicotyledonous crops, delivering unparalleled expertise in this high-growth market segment.
Solving Recalcitrance
Our goal is to deliver fast, reproducible, and high-efficiency CRISPR-based edits in crops traditionally considered recalcitrant to genetic manipulation, overcoming long-standing biological and technical bottlenecks in plant transformation and regeneration.
What makes CropEditas™ different?
CropEditas™ is not just a tool—it is an end-to-end strategic proprietary solution:
Built from the ground up
Unlike other CRISPR platforms, CropEditas™ is a fully customized gene-editing pipeline. We understand our partners’ needs and build a perfect match for them.
Reproducible & Scalable
The 360° One-Stop Global Partnership: Our process ensures high-efficiency, consistent results, providing partners with an end-to-end service from trait discovery to commercialization.
IP-Protected & Globally Licensed
Our system is PCT-Filed and IP-Protected, providing global commercial rights for CRISPR use across all crops and eliminating common licensing barriers for our partners.
Product Development Pipeline
Our process is designed to reduce cycles even for long-cycle specialty crops, ensuring a significantly lower time and cost to market.
Short Life Cycle (E.g. Peanut)
Long Life Cycle (E.g. Citrus)
Work hand-in-hand with partners to take edited crops to market, navigating regulatory approval, field trials, registration, and a successful commercial launch
Advanced genome editing The speed and precision advantage
CropEditas™ provides a faster, cost-effective, and more predictable path to market by enabling:
Speed and Cost Efficiency:
Faster and less expensive than traditional breeding, with fast and inexpensive CRISPR regulatory approval for field trials.
Targeted Traits:
Precise edit of targeted genes, delivering stable traits and a Non-GMO end product.
Multiplex Editing:
Ability to add multiple traits at once for complex and efficient solution development.
Scientific leadership and gene discovery services
Gene discovery services
Identification of high-value gene–trait associations across crops using GBS, GWAS, and comparative genomics, executed both in-house and through partnerships with AI-driven software companies to enable confident target-gene discovery.
Transformation expertise
Dr. Chandrakanth Emani, Research Scientist, brings over 25 years of hands-on experience in genetic transformation and holds multiple patents in plant genetic engineering.
CRISPR Authority
Dr. Arturo Ortega, Research Scientist, was part of the research team of the Nobel Laureate CRISPR discoverer Jennifer Doudna.